Prepare for your visit

Temitope Adebusoye

Psychiatric/Mental Health (Nurse Practitioner) · Bowie, MD · NPI 1346917200

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,393.02

in general payments reported to CMS, 2019-2025 · $284 in 2025

The $284 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).

Who reported paying

General payments only, top 6 by amount.

Abbvie INC. $472.63
Otsuka America Pharmaceutical, INC. $267.72
Janssen Pharmaceuticals, INC $181.91
Lundbeck LLC $114.67
Neurocrine Biosciences, INC. $114.67
Teva Pharmaceuticals USA, INC. $77.92

Drugs and devices associated with these payments

Vraylar Rexulti Invega Sustenna Abilify Asimtufii Abilify Maintena Invega Trinza Qelbree Aristada Caplyta Ingrezza Vivitrol Spravato

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Temitope Adebusoye listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10654222/temitope-adebusoye